1,045
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

The pre-operative neutrophil–lymphocyte ratio predicts overall and disease-free survival following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with pseudomxyoma peritonei of appendiceal origin

ORCID Icon, ORCID Icon, , , &
Pages 559-563 | Received 25 Jul 2017, Accepted 20 Sep 2017, Published online: 24 Oct 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (9)

Kandiah Chandrakumaran, Norman John Carr, Faheez Mohamed, Thomas Desmond Cecil & Brendan John Moran. (2023) Development and Validation of Nomograms to Predict Survival in Patients Undergoing Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei of Appendiceal Origin. JAMA Surgery 158:5, pages 522.
Crossref
Thale D.J.H. Patrick-Brown, Faheez Mohamed, Andrew Thrower, Annette Torgunrud, Sarah Cosyns, Emel Canbay, Laurent Villeneuve, Kjersti Flatmark & Andreas Brandl. (2023) Determining a minimum data set for reporting clinical and radiologic data for pseudomyxoma peritonei. Pleura and Peritoneum 8:1, pages 1-9.
Crossref
Antoine El Asmar, Martin Delcourt, Leonel Kamden, Charif Khaled, Ali Bohlok, Michel Moreau, Francesco Sclafani, Vincent Donckier & Gabriel Liberale. (2022) Prognostic Value of Preoperative Serological Biomarkers in Patients Undergoing Curative-Intent Cytoreductive Surgery for Colorectal Cancer Peritoneal Metastases. Annals of Surgical Oncology 30:3, pages 1863-1869.
Crossref
Tai-Chuan Kuan, Wen-Yi Liang, Chun-Chi Lin, Hung-Hsin Lin, Sheng-Chieh Huang, Ho-Shuan Cheng, Shih-Ching Chang, Jeng-Kai Jiang & Yuan-Tzu Lan. (2022) Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio on low-grade appendiceal mucinous neoplasm: A single tertiary hospital experience. Journal of the Chinese Medical Association 85:6, pages 693-698.
Crossref
Noah S. Rozich, Samara E. Lewis, Sixia Chen, Kenneth E. Stewart, Michael B. Stout, William C. Dooley, Laura E. Fischer & Katherine T. Morris. (2021) Women survive longer than men undergoing cytoreductive surgery and HIPEC for appendiceal cancer. PLOS ONE 16:4, pages e0250726.
Crossref
Yaniv Zager, Aviad Hoffman, Yael Dreznik, Harel Jacoby, Mordehay Cordoba, Nir Horesh, Avinoam Nevler, Mordechai Gutman & Yaniv Berger. (2020) Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer: The prognostic impact of baseline neutrophil-lymphocyte, platelet-lymphocyte and lymphocyte-monocyte ratios. Surgical Oncology 35, pages 321-327.
Crossref
Alessandra Raimondi, Salvatore Corallo, Monica Niger, Maria Antista, Giovanni Randon, Federica Morano, Massimo Milione, Shigeki Kusamura, Dario Baratti, Marcello Guaglio, Chiara Cremolini, Federica Marmorino, Maria Di Bartolomeo, Marcello Deraco, Filippo De Braud & Filippo Pietrantonio. (2019) Metronomic Capecitabine With Cyclophosphamide Regimen in Unresectable or Relapsed Pseudomyxoma Peritonei. Clinical Colorectal Cancer 18:2, pages e179-e190.
Crossref
Kim, Chun, Kim, Kim, Baik, Hong, Kim & Shin. (2019) Prognostic Value of Systemic Inflammatory Indices, NLR, PLR, and MPV, for Predicting 1-Year Survival of Patients Undergoing Cytoreductive Surgery with HIPEC. Journal of Clinical Medicine 8:5, pages 589.
Crossref
Syed Ali Rizvi, Wajahat Syed & Ravi Shergill. (2018) Approach to pseudomyxoma peritonei. World Journal of Gastrointestinal Surgery 10:5, pages 49-56.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.